Related Experiment Video
Updated: Mar 6, 2026
06:16
Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
3.2K
Novel therapeutics for Stargardt disease
Louise J Lu1, Ji Liu1, Ron A Adelman2
1Department of Ophthalmology and Visual Science, Yale School of Medicine, 40 Temple St., New Haven, CT, 06510, USA.
Summary
Stargardt disease, an inherited retinal disorder, lacks treatments but shows promise with new therapies. This review covers emerging pharmacologic, gene, and stem-cell treatments to potentially restore vision.
Area of Science:
- Ophthalmology
- Genetics
- Regenerative Medicine
Background:
- Stargardt disease is an inherited macular dystrophy caused by ABCA4 gene mutations.
- It is the most common form of macular degeneration in children, leading to severe vision loss.
- Currently, no standard treatments exist for Stargardt disease.
Purpose of the Study:
- To systematically review and summarize recent advancements in Stargardt disease therapies.
- To explore novel therapeutic strategies including pharmacologic, gene, and stem-cell approaches.
- To assess the potential of these treatments in improving vision for affected patients.
Main Methods:
- Systematic literature review of Stargardt disease therapies.
- Analysis of evidence for pharmacologic agents (ALK-001, fenretinide, A1120).
- Evaluation of gene therapy (StarGen™) and stem-cell therapy (hESC-RPE).
Main Results:
- Pharmacologic agents aim to modulate the visual cycle.
- Gene therapy seeks to supplement the functional ABCA4 gene.
- Stem-cell therapy focuses on retinal pigment epithelium regeneration.
Conclusions:
- Innovative therapies show promise for Stargardt disease treatment.
- Pharmacologic, gene, and stem-cell approaches represent potential strategies to prevent vision loss.
- Further research is needed to establish efficacy and safety of these novel treatments.
Keywords:
Gene therapyMacular degenerationMacular dystrophyPharmacologic therapyRetinal pigment epitheliumStargardt diseaseStem-cell transplantationMore Related Videos
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55
01:22iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
00:59Gene Therapy
27.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.9K
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:15Drugs that Stabilize Microtubules
2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K